N. Yusoh

The metallo-intercalator [Ru(dppz)2(PIP)]2+ renders BRCA wild-type triple-negative breast cancer cells hypersensitive to PARP inhibition.

M. B. A. Rahman, S. Chia, Martin R. Gill, 2020, ACS chemical biology.

Combining PARP Inhibition with Platinum, Ruthenium or Gold Complexes for Cancer Therapy

Martin R. Gill, H. Ahmad, N. Yusoh, 2020, ChemMedChem.

Synergy of ruthenium metallo-intercalator, [Ru(dppz)2(PIP)]2+, with PARP inhibitor Olaparib in non-small cell lung cancer cells

S. Chia, N. Saad, Martin R. Gill, 2023, Scientific Reports.

Discovery of Ruthenium(II) Metallocompound and Olaparib Synergy for Cancer Combination Therapy

Jim A. Thomas, S. Chia, N. Saad, 2023, Journal of medicinal chemistry.

Ruthenium(II) Polypyridyl Complexes as FRET Donors: Structure- and Sequence-Selective DNA-Binding and Anticancer Properties

Martin R. Gill, M. Davies, H. Ahmad, 2023, Journal of the American Chemical Society.

Effect of operating conditions on crude oil fouling through CFD simulations

Sampath Emani, Ramasamy Marappa Gounder, Ku Zilati Ku Shaari, 2017 .